Bone-Protecting Agents Reduce Fractures Associated With Treatment in Metastatic Castration-Resistant Prostate Cancer
The cumulative incidence of bone fractures was below 5% in BPA recipients.
Bone Disorders
Study: Etelcalcetide Can Be Used Safely in Diabetic Nephropathy
Etelcalcetide use in patients with diabetic nephropathy might protect against development of adynamic bone disease, according to investigators.
Kidney Stones Linked With Osteoporosis, Fractures
Bone loss in patients with kidney stone disease, particularly in men, has been underappreciated in clinical practice, according to investigators.
BMD Testing Rates Low in Men Initiating ADT for Prostate Cancer
Odds of BMD testing up with history of osteoporosis, rheumatoid arthritis, bisphosphonate use.
Risk of Nonspinal Fracture Increased in Moderate to Severe CKD
Fracture prevention efforts should be considered in patients with CKD of any age, according to investigators.
Longer Bisphosphonate Use May Up Atypical Femur Fracture Risk
Rapid decline in atypical fracture risk seen when bisphosphonate discontinued in women ≥50 years.
Longer Bisphosphonate Drug Holiday May Up Fracture Risk
For those with previous vertebral fracture, major osteoporotic fractures increased with holidays >12 months.
Vertebral Fractures Up With Long-Term Delay of Denosumab
Increase in risk with long delay of subsequent doses not significant for composite of all fracture types.
Promising Early Results for Use of Teriparatide in the Treatment of Medication-Related Osteonecrosis of the Jaw
This study is the first placebo-controlled clinical trial to investigate a treatment for MRONJ in patients for whom the condition is established.
ASCO Releases Guideline on Addressing Osteoporosis Risk With Nonmetastatic Cancer
The guideline includes strategies to identify patients with nonmetastatic cancer who may be at a higher risk for osteoporotic fractures.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...